EarningsSQURPHARMA
SQURPHARMA Earnings Update
Announcement summary
- What happened
- SQURPHARMA published a corporate disclosure on 14 November 2019. Read the full announcement for details.
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 4.25 for July-September 2019 as against Tk. 4.02 for July-September 2018; Consolidated NOCFPS was Tk. 4.14 for July-September 2019 as against Tk. 4.06 for July-September 2018. Consolidated NAV per share was Tk. 90.00 as on September 30, 2019 and Tk. 86.03 as on June 30, 2019.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b00004005849b
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.